1981
|
|
|
C-C motif chemokine ligand 21 |
6Ckine, CKb9, ECL, SCYA21, SLC, TCA4 |
|
1982
|
|
|
C-C motif chemokine ligand 22 |
A-152E5.1, ABCD-1, DC/B-CK, MDC, SCYA22, STCP-1 |
|
1983
|
|
|
C-C motif chemokine ligand 23 |
CK-BETA-8, CKb8, Ckb-8, Ckb-8-1, MIP-3, MIP3, MPIF-1, SCYA23, hmrp-2a |
|
1984
|
|
|
C-C motif chemokine ligand 24 |
Ckb-6, MPIF-2, MPIF2, SCYA24 |
|
1985
|
|
|
C-C motif chemokine ligand 25 |
Ck beta-15, Ckb15, SCYA25, TECK, TECKvar |
|
1986
|
|
|
C-C motif chemokine ligand 26 |
IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1 |
|
1987
|
|
|
C-C motif chemokine ligand 27 |
ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27 |
|
1988
|
|
|
C-C motif chemokine ligand 28 |
CCK1, MEC, SCYA28 |
|
1989
|
|
|
C-C motif chemokine ligand 3 |
G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI, SCYA3 |
Atherosclerosis, Brain ischemia, Hepatocellular carcinoma, Colonic neoplasms, Color vision deficiency, Glomerulonephritis, Hypersensitivity, Mesothelioma, Myocardial ischemia, Pulmonary fibrosis, Status epilepticus |
1990
|
|
|
C-C motif chemokine ligand 3 like 3 |
464.2, D17S1718, G0S19-2, LD78, LD78BETA, SCYA3L, SCYA3L1 |
|